Bioventus BVS International — Total Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's international — total net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bioventus's international — total net sales?
- Bioventus (BVS) reported international — total net sales of $15.64M in Q1 2026.
- How has Bioventus's international — total net sales changed year-over-year?
- Bioventus's international — total net sales increased by 17.1% year-over-year, from $13.36M to $15.64M.
- What is the long-term trend for Bioventus's international — total net sales?
- Over 4 years (2021 to 2025), Bioventus's international — total net sales has grown at a 11.1% compound annual growth rate (CAGR), from $43.35M to $65.99M.
- What does international — total net sales mean?
- Measures the total revenue generated from the sale of goods and services within the international geographic segment, net of returns, allowances, and discounts. It is a primary indicator of the company's market penetration and demand for its medical technology products in global markets.